Clinical Trial Update: Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types) [Phase 2]

View source ↗

Summary

Phase 2 study update for FYU-981 in hyperuricemia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia

Drugs mentioned

• FYU-981

Snippet

Sponsor: Fuji Yakuhin Co., Ltd. | Conditions: Hyperuricemia | Phase 2 | Status: COMPLETED